Drug Description in Trials / DrugBank / KEGG DRUG

Search results

descriptions per page:

Showing 1 to 4 of 4 descriptions

Filter by |

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Benralizumab
(Fasenra (TN))

[1] Benralizumab (Fasenra)

[1] Benralizumab (Fasenra (TN)) 💬

[1] IL5RA 💬

[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ...

[5] 44, 45, 98, 162, 299 💬

2

Biological: Benralizumab, Biological: Placebo to Mepolizumab
(Fasenra (TN))

[2] Benralizumab (Fasenra),
Mepolizumab

[2] Mepolizumab ,
Benralizumab (Fasenra (TN)) 💬

[2] IL5,
IL5RA 💬

[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction ...

[1] 44 💬

3

Biological: Mepolizumab, Biological: Placebo to Benralizumab
(Fasenra (TN))

[2] Benralizumab (Fasenra),
Mepolizumab

[2] Mepolizumab ,
Benralizumab (Fasenra (TN)) 💬

[2] IL5,
IL5RA 💬

[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction ...

[1] 44 💬

4

[1] Benralizumab (Fasenra)

[1] Benralizumab (Fasenra (TN)) 💬

[1] IL5RA 💬

[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ...

[5] 44, 45, 98, 162, 299 💬

First Previous1Next Last